184 related articles for article (PubMed ID: 21751570)
21. Absence of anti-cyclic citrullinated peptide antibodies in erosive osteoarthritis: further serological evidence of the disease as a subset of osteoarthritis.
Morozzi G; Bellisai F; Fioravanti A; Galeazzi M
Ann Rheum Dis; 2005 Jul; 64(7):1095-6. PubMed ID: 15958771
[No Abstract] [Full Text] [Related]
22. The role of anti-cyclic citrullinated peptide antibodies in predicting progression of palindromic rheumatism to rheumatoid arthritis.
Russell AS; Devani A; Maksymowych WP
J Rheumatol; 2006 Jul; 33(7):1240-2. PubMed ID: 16724377
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of three automated enzyme immunoassays for detection of anti-cyclic citrullinated peptide antibodies in qualitative and quantitative aspects.
Kim S; Kim JH; Lee JH; Kim HS
Rheumatology (Oxford); 2010 Mar; 49(3):450-7. PubMed ID: 20028730
[TBL] [Abstract][Full Text] [Related]
24. Testing for anti-cyclic citrullinated peptide antibodies: is it time to set this genie free?
Shmerling RH
Arch Intern Med; 2009 Jan; 169(1):9-14. PubMed ID: 19139318
[No Abstract] [Full Text] [Related]
25. The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis.
Korendowych E; Owen P; Ravindran J; Carmichael C; McHugh N
Rheumatology (Oxford); 2005 Aug; 44(8):1056-60. PubMed ID: 15901902
[TBL] [Abstract][Full Text] [Related]
26. Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis?
Girelli F; Foschi FG; Bedeschi E; Calderoni V; Stefanini GF; Martinelli MG
Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):127-30. PubMed ID: 15180353
[TBL] [Abstract][Full Text] [Related]
27. Anti-cyclic citrullinated peptide autoantibodies in IgM rheumatoid factor-positive patients.
García-Berrocal B; González C; Pérez M; Navajo JA; Moreta I; Dávila C; González-Buitrago JM
Clin Chim Acta; 2005 Apr; 354(1-2):123-30. PubMed ID: 15748608
[TBL] [Abstract][Full Text] [Related]
28. Serum autoantibodies that bind citrullinated fibrinogen are frequently found in patients with rheumatoid arthritis.
Hill JA; Al-Bishri J; Gladman DD; Cairns E; Bell DA
J Rheumatol; 2006 Nov; 33(11):2115-9. PubMed ID: 16924693
[TBL] [Abstract][Full Text] [Related]
29. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis.
Abdel-Nasser AM; Mahmoud MH; El Mansoury TM; Osman AM
Scand J Rheumatol; 2008; 37(5):329-36. PubMed ID: 18666028
[TBL] [Abstract][Full Text] [Related]
30. IgM-rheumatoid factor, anti-cyclic citrullinated peptide, and anti-citrullinated human fibrinogen antibodies decrease during treatment with the tumor necrosis factor blocker infliximab in patients with rheumatoid arthritis.
Vis M; Bos WH; Wolbink G; Voskuyl AE; Twisk JW; Van de Stadt R; Hamann D; Dijkmans BA; Lems WF
J Rheumatol; 2008 Mar; 35(3):425-8. PubMed ID: 18322974
[TBL] [Abstract][Full Text] [Related]
31. Is it necessary to combine detection of anticitrullinated protein antibodies in the diagnosis of rheumatoid arthritis?
Zhao J; Liu X; Wang Z; Liu R; Li Z
J Rheumatol; 2010 Dec; 37(12):2462-5. PubMed ID: 20952480
[TBL] [Abstract][Full Text] [Related]
32. Role of anticyclic citrullinated peptide in the diagnosis of early rheumatoid factor-negative suspected rheumatoid arthritis: is it worthwhile to order the test?
Panchagnula R; Rajiv SR; Prakash J; Chandrashekara S; Suresh KP
J Clin Rheumatol; 2006 Aug; 12(4):172-5. PubMed ID: 16891919
[TBL] [Abstract][Full Text] [Related]
33. A combined diagnostic approach to rheumatoid arthritis using anti-cyclic citrullinated peptide antibodies and rheumatoid factor.
Oommen S; Appalaraju B; Sivadarshini S;
Indian J Med Microbiol; 2011; 29(2):195-6. PubMed ID: 21654124
[No Abstract] [Full Text] [Related]
34. Easy and accurate diagnosis of rheumatoid arthritis using anti-cyclic citrullinated peptide 2 antibody, swollen joint count, and C-reactive protein/rheumatoid factor.
Yamane T; Hashiramoto A; Tanaka Y; Tsumiyama K; Miura Y; Shiozawa K; Chihara K; Shiozawa S
J Rheumatol; 2008 Mar; 35(3):414-20. PubMed ID: 18203327
[TBL] [Abstract][Full Text] [Related]
35. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
[TBL] [Abstract][Full Text] [Related]
36. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
[TBL] [Abstract][Full Text] [Related]
37. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
Liu X; Jia R; Zhao J; Li Z
J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936
[TBL] [Abstract][Full Text] [Related]
38. Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.
Innala L; Kokkonen H; Eriksson C; Jidell E; Berglin E; Dahlqvst SR
J Rheumatol; 2008 Jun; 35(6):1002-8. PubMed ID: 18398946
[TBL] [Abstract][Full Text] [Related]
39. Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review.
Lee AN; Beck CE; Hall M
Clin Lab Sci; 2008; 21(1):15-8. PubMed ID: 18335856
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.
Mofidi M; Moghadam A
Saudi Med J; 2008 Aug; 29(8):1206-7. PubMed ID: 18690324
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]